Clinical Trial Update: Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study. [Phase 2]

View source ↗

Summary

Phase 2 randomized multicenter study comparing intravenous ferric carboxymaltose to oral iron for iron deficiency anemia in patients with metastatic colorectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Oral iron therapy (iron (oral))
• ferric carboxymaltose (intravenous) (ferric carboxymaltose)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED